← Evidence map

ArticleExpert review of anticancer therapy2023

A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.

M Lia Palomba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36723678